BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17906670)

  • 1. Diagnosis or drug? Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine?
    Kling J
    EMBO Rep; 2007 Oct; 8(10):903-6. PubMed ID: 17906670
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
    Issa AM
    Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How personalized medicine is changing the rules of drug life exclusivity.
    Sullivan CG
    Pharmacogenomics; 2004 Jun; 5(4):429-32. PubMed ID: 15165178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and cost-effectiveness analysis: a two-way street.
    Chalkidou K; Rawlins M
    Drug Discov Today; 2011 Oct; 16(19-20):873-7. PubMed ID: 21903176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications.
    Di Francia R; Berretta M; Catapano O; Canzoniero LM; Formisano L
    Clin Chem Lab Med; 2011 Jul; 49(7):1105-11. PubMed ID: 21504372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics and pharmacogenetics: future role of molecular diagnostics in the clinical diagnostic laboratory.
    Ito RK; Demers LM
    Clin Chem; 2004 Sep; 50(9):1526-7. PubMed ID: 15331499
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular diagnostics and personalized medicine. IBC Life Sciences Conference on Pharmacogenomics, June 24-25, 2003, London, UK.
    Sanders R
    Pharmacogenomics; 2003 Sep; 4(5):541-5. PubMed ID: 14518454
    [No Abstract]   [Full Text] [Related]  

  • 10. Stratified medicine: making it happen.
    Foot E
    Drug Discov Today; 2011 Oct; 16(19-20):848-9. PubMed ID: 21920455
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity.
    Johnson JA; Evans WE
    Trends Mol Med; 2002 Jun; 8(6):300-5. PubMed ID: 12067617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized medicine: challenges in assessing and capturing value in the commercial environment.
    Ferrara J
    Expert Rev Mol Diagn; 2006 Mar; 6(2):129-31. PubMed ID: 16512770
    [No Abstract]   [Full Text] [Related]  

  • 13. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
    Ross JS; Ginsburg GS
    Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of genetics to personalize medicine.
    Chung WK
    Gend Med; 2007 Sep; 4(3):248-65. PubMed ID: 18022591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing pharmacogenetic evidence throughout clinical development.
    Burns DK
    Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostic testing in breast cancer.
    Berse B; Lynch JA
    Semin Oncol Nurs; 2015 May; 31(2):108-21. PubMed ID: 25951740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.
    Bissonnette L; Bergeron MG
    Expert Rev Mol Diagn; 2006 May; 6(3):433-50. PubMed ID: 16706745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
    Walk EE
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: where and how could biomarkers be used in 2016?
    Finley Austin MJ; Babiss L
    AAPS J; 2006; 8(1):E185-9. PubMed ID: 16596744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.